Jane Street’s Sonoma Pharmaceuticals SNOA Stock Holding History

Jane Street’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,265	Closed	-$9.61K	–	10348
2024 Q2	$9.61K	Buy	+2,265	New	+$8.05K	﹤0.01%	9109
2019 Q2	–	Sell	-63	Closed	-$11K	–	5683
2019 Q1	$11K	Buy	+63	New	+$9.53K	﹤0.01%	4918
2015 Q3	–	Sell	-61	Closed	-$78K	–	4104
2015 Q2	$78K	Buy	+61	New	+$57.1K	﹤0.01%	3471
2014 Q4	–	Sell	-13	Closed	-$28K	–	2995
2014 Q3	$28K	Sell	13 -13	-50%	-$30.2K	﹤0.01%	2452
2014 Q2	$72K	Buy	+26	New	+$76.9K	﹤0.01%	2397

Other funds holding SNOA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Jane Street's SNOA Position: Q3 2024 in Review

Jane Street sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2024, closing a stake of 2,265 shares — an estimated $9.61K sold.

Jane Street first reported a position in SNOA in Q2 2014 and held it in 5 quarters. The position peaked at $78K in Q2 2015. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

Jane Street reported no remaining Sonoma Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Jane Street sold 2,265 Sonoma Pharmaceuticals shares in Q3 2024, an estimated $9.61K.
Jane Street first reported a position in Sonoma Pharmaceuticals in Q2 2014 and held it in 5 quarters.
Jane Street's Sonoma Pharmaceuticals position peaked at $78K in Q2 2015.
14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.